The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...
Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest ...
Investor's Business Daily on MSN4d
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedDexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...
Spread the loveTable of Contents Introduction Methodology Top 10 Smart Device Giants Rising Stars (11-25) Innovators and Disruptors (26-50) Specialized Leaders (51-75) Emerging Powerhouses (76-100) ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
CyberArk and Device Authority, in collaboration with Microsoft, have launched a solution that strengthens and scales connected device authentication to enterprise applications with Zero Trust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback